While the Windows maker did not attribute the activity to a specific threat actor, the use of VS Code tasks and Vercel ...
Mobile platforms operate under fundamentally different trust assumptions than we relied on for web security. Your mobile ...
The Microsoft Defender team has discovered a coordinated campaign targeting software developers through malicious repositories posing as legitimate Next.js projects and technical assessment materials, ...
A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...
Boris Cherny is the lead engineer at AI giant Anthropic, best known as the creator of Claude Code, a tool made to help ...
Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Slop’ pull requests from LLMs are deluging maintainers, and you can generate small utility functions on your own in seconds. The open source world is grappling with AI.
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Systems like OpenAI’s GPT-5 are accelerating research in math, biology and chemistry. But there is a debate over whether it can do that work on its own. Credit...Agnes Jonas Supported by By Cade Metz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results